Daré Bioscience (DARE) has issued an announcement.
Daré Bioscience, Inc. has announced a reverse stock split of its common stock at a ratio of 1-for-12, effective July 1, 2024. This strategic move, approved by stockholders, will consolidate every 12 shares into one, reducing the total issued shares from about 101.1 million to 8.4 million without altering the authorized share count or par value. The adjustment aims to proportionately affect all shareholders, maintaining their ownership percentages except for minor changes due to the rounding of fractional shares. The stock will continue to trade under the ticker “DARE” with a new CUSIP number, and the reverse split will also proportionally adjust the terms of outstanding stock options and warrants.
See more data about DARE stock on TipRanks’ Stock Analysis page.
